Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IST vs IPT for Malaria in Malawian Schoolchildren
NCT05244954Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Feb 2022
- Primary completion
- Aug 2022
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dihydroartemisinin + piperaquine and chloroquine in Plasmodium falciparum malaria (3 arms), sponsored by University of Maryland, Baltimore. Primary endpoints: P. falciparum infection and P. falciparum gametocyte carriage. Started Feb 2022; status: completed.
02
Drugs
dihydroartemisinin + piperaquinechloroquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT05244954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05244954.